Skip to main content
. Author manuscript; available in PMC: 2021 Apr 27.
Published in final edited form as: JACC Cardiovasc Interv. 2020 Feb 12;13(8):938–950. doi: 10.1016/j.jcin.2019.11.027

Table 3:

Management and in-hospital outcomes of different types of ACS after TAVR

Unstable angina (n = 208) NSTEMI (n = 5,947) STEMI (n = 586) p value
N 208 5,947 586
Length of hospital stay,days 3 (1–4) 4 (2–7) 4 (2–8) <0.0001
Early discharge (≤72 h) 66.4 38.3 29.2 <0.0001
Discharge destination
Home 62.5 37.4 32.9 <0.001
SNF - 19.3 12.3
Home health care 15.4 19.1 12.8
Acute rehabilitation - 2.8 2.2
Cardiogenic shock - 3.5 15.0 <0.001
Cardiac arrest - 2.9 13.0 <0.001
Blood transfusion 7.7 11.2 9.9 0.19
Acute kidney injury 8.2 33.2 32.4 <0.001
Acute heart failure - 34.7 25.1 <0.0001
In-hospital mortality - 7.6 24.1 <0.0001
30-day readmission for recurrent ACS 4.9 12.1 28.5 <0.0001
30-day need for intervention (after discharge from index ACS admission) 6.8 4.0 4.0 0.1
30-day heart failure - 4.1 5.5 0.04
30-day bleeding - 2.5 - 0.07
30-day mortality - 15.5 31.4 <0.0001
1-yr mortality 26.0 41.3 51.2 <0.0001
ACS inpatient management
Invasive approach 30.3 28.5 48.1 <0.001
Drug eluting stenting —13.9 11.8 21.3 <0.001
Bare metal stenting - 1.4 6.0 <0.001
Number of vessels treated*
1 80.0 80.4 82.7 0.59
2 16.7 16.6 12.2
≥3 - 3.0 5.1
Number of stents placed*
1 65.6 75.4 73.1 0.16
2 28.1 18.0 14.7
≥3 6.3 6.6 12.2
Coronary angiography without intervention 13.0 13.9 13.8 0.92
Plain old balloon angioplasty alone - 1.4 7.2 <0.001
Urgent CABG 0.0 0.5 - 0.48
Use of coronary intravascular ultrasound - 1.2 2.4 0.02
Mechanical circulatory support (IABP, ECMO, Impella) - 1.4 7.2 <0.001
Nuclear myocardial perfusion imaging testing 12.5 10.4 3.8 <0.001

Values are median (interquartile range) or %.

Cells with N <10 were suppressed with (–).

CABG = coronary artery bypass grafting; ECMO = extracorporeal membrane oxygenation; IABP = intra-aortic balloon pump; SNF = skilled nursing facility; other abbreviations as in Tables 1 and 2.

*

These are proportions out of patients who had PCI with drug-eluting stent or bare-metal stent. Missing data are <1% for both variables.